Recombinant Human IL-1α
Recombinant Human IL-1α
Product No.: I-182
Alternate Names Interleukin-1 Alpha, Hematopoietin-1, Lymphocyte-Activating Factor [LAF], Endogenous Pyrogen [EP], Leukocyte Endogenous Mediator [LEM], Mononuclear Cell Factor [MCF] Product Type Recombinant Protein Expression Host E. coli Cells Species Human |
Data
BackgroundIL-1R1 is an 80 kD transmembrane glycoprotein and a member of the Ig superfamily. IL-1 binds both IL-1R1 and IL-1R2. The ligands IL-1α and IL-1β only commence when binding IL-1R1 because IL-1R2 acts as a decoy receptor and competitively antagonizes the binding of IL-1α and IL-1β, thereby reducing their biological effects. Binding of the ligands to IL-1R1 is enhanced by an accessory protein, IL-1R-AcP. IL-1α can exist as either a 31 kD precursor or an 18 kD mature form. IL-1α is a proinflammatory cell-associated cytokine and IL-1β is a 17.5 kD proinflammatory secreted cytokine. Both IL-1α and IL-1β bind to the same receptor and have similar properties that include stimulation of thymocyte proliferation via IL-2 release, B-cell maturation and proliferation, mitogenic FGF-like activity and the ability to stimulate the release of prostaglandin and collagenase from synovial cells. Furthermore, IL-1β mediates a variety of immune and inflammatory responses. IL-1β is a major cause of severe inflammation in the mouse model of Crohn’s Disease, which makes IL-1β an important target for this disease. Protein DetailsPurity >97% by SDS-PAGE and analyzed by silver stain. Endotoxin Level <0.1 EU/µg as determined by the LAL method Biological Activity The biological activity of Human IL-1 Alpha was determined in a cell proliferation assay using the murine helper T cell line, D10.G4.1 (Symons, J.A. et al., in Lymphokines and Interferons, a Practical Approach, 1987, M.J. Clemens, A.G. Morris, and A.J.H. Gearing, eds., IRL Press, p. 272). The expected ED<sub>50</sub> for this effect is typically 3 - 7 pg/ml. Protein Accession No. Q53QF9 Amino Acid Sequence sapfsfls nvkynfmrii kyefilndal nqsiirandq yltaaalhnl deavkfdmga yksskddaki tvilrisktq lyvtaqdedq pvllkempei pktitgsetn llffwethgt knyftsvahp nlfiatkqdy wvclaggpps itdfqilenq a
N-terminal Sequence Analysis Ser113 State of Matter Solution Predicted Molecular Mass The predicted molecular weight of Recombinant Human IL-1α is Mr 18 kDa. Additionally, the actual molecular weight as observed by migration on SDS-PAGE is 18 kDa (reducing conditions). Predicted Molecular Mass 18 Formulation This recombinant protein solution was 0.2 µm filtered and formulated in modified Dulbecco’s phosphate buffered saline (1X PBS) pH 7.2 – 7.3 with no calcium, magnesium, or preservatives present. Storage and Stability Working aliquots of human rIL-1 alpha are stable for up to twelve months at -20° C to -70° C in a manual defrost freezer. Upon thawing, rIL-1 alpha, in the presence of a carrier protein, can be stored at 2° - 8°C for one month without detectable loss of activity. For long-term storage, aliquot and freeze at -20° C to -70° C in a manual defrost freezer. Avoid repeated freeze thaw cycles. Country of Origin USA Shipping Dry Ice Leinco Protein AdvisorPowered by AI: AI is experimental and still learning how to provide the best assistance. It may occasionally generate incorrect or incomplete responses. Please do not rely solely on its recommendations when making purchasing decisions or designing experiments. Recombinant Human IL-1α is a valuable tool for a wide range of research applications due to its central role in inflammation, immune regulation, and tissue homeostasis. Here are several compelling reasons to use Recombinant Human IL-1α in your research: 1. Key Mediator of InflammationIL-1α is a potent pro-inflammatory cytokine that initiates and amplifies inflammatory responses. It acts as an "alarmin," rapidly released from damaged or dying cells to alert the immune system during sterile injury, infection, or tissue stress. This makes it essential for studying:
2. Broad Biological ActivityRecombinant IL-1α is biologically active and can stimulate a variety of cellular responses in vitro and in vivo, including:
3. Use as a Positive ControlIL-1α is widely used as a positive control in assays involving inflammation, immune cell activation, and tissue remodeling. For example:
4. Role in Disease ModelsIL-1α is implicated in the pathogenesis of several diseases, including:
Using recombinant IL-1α allows researchers to model these conditions and test potential therapeutic interventions. 5. High Specificity and PurityRecombinant IL-1α is available in highly purified, carrier-free forms, ensuring minimal batch-to-batch variability and reducing the risk of confounding effects from contaminants. 6. Compatibility with Diverse AssaysRecombinant IL-1α is suitable for a wide range of experimental applications, including:
7. Therapeutic Target ValidationIL-1α is a validated target for therapeutic intervention. Using recombinant IL-1α in your research allows you to:
8. Relevance to Translational ResearchFindings using recombinant IL-1α can be directly translated to clinical settings, as IL-1α inhibitors are already in use or under investigation for treating inflammatory diseases, cancer, and autoimmune disorders. In summary, Recombinant Human IL-1α is a versatile and reliable reagent for studying inflammation, immune responses, and disease mechanisms. Its broad biological activity, high purity, and relevance to both basic and translational research make it an essential tool for any laboratory investigating inflammatory or immune-related processes. Yes, recombinant human IL-1α can be used as a standard for quantification or calibration in ELISA assays, provided it is compatible with your assay system. This is a common practice in research ELISAs for cytokines such as IL-1α. Key considerations and supporting details:
Summary Table: Use of Recombinant Human IL-1α as ELISA Standard
In summary: Recombinant human IL-1α is suitable and commonly used as a standard in ELISA assays for quantification and calibration, provided it is compatible with your assay’s antibodies and protocol. Always validate performance in your specific assay context. Recombinant Human IL-1α has been validated for a wide range of applications in published research, including:
These applications highlight the versatility of Recombinant Human IL-1α in both basic research and translational studies, particularly in the context of inflammation, immune response, and disease modeling. To reconstitute and prepare Recombinant Human IL-1α protein for cell culture experiments, dissolve the lyophilized protein in sterile PBS (pH 7.4), ideally supplemented with 0.1% endotoxin-free human or bovine serum albumin (HSA or BSA) to a working concentration suitable for your assay, commonly 10–200 μg/mL depending on experimental needs. Step-by-step protocol:
Additional notes:
Summary Table:
This protocol ensures optimal solubility, stability, and biological activity of recombinant human IL-1α for cell culture experiments. References & Citations1. Arend, WP. et al. (2003) Cytokine Growth Factor Rev. 13:323 2. Nicklin, MJ. et al. (1994) Genomics 19:382 3. Dunn, E. et al. (2001) Trends Immunol. 22:533 4. Hardy, R. et al. (2009) J. Endocrinol. 201:309 Certificate of AnalysisIMPORTANT Use lot specific datasheet for all technical information pertaining to this recombinant protein. |
Related Products
Prod No. | Description |
|---|---|
I-658 | |
I-628 | |
I-182 | |
I-671 | |
I-144 | |
I-161 | |
I-341 | |
I-653 | |
I-204 | |
I-334 |
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
